Glenmede Trust Co. NA decreased its stake in UiPath Inc. (NYSE:PATH - Free Report) by 76.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 552,463 shares of the company's stock after selling 1,838,981 shares during the quarter. Glenmede Trust Co. NA owned approximately 0.10% of UiPath worth $7,072,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of PATH. Advisors Asset Management Inc. lifted its position in shares of UiPath by 35.0% in the first quarter. Advisors Asset Management Inc. now owns 3,037 shares of the company's stock valued at $69,000 after acquiring an additional 787 shares in the last quarter. Lazard Asset Management LLC boosted its stake in UiPath by 16,741.9% during the 1st quarter. Lazard Asset Management LLC now owns 5,221 shares of the company's stock worth $118,000 after purchasing an additional 5,190 shares during the last quarter. Comerica Bank boosted its stake in UiPath by 226.5% during the 1st quarter. Comerica Bank now owns 25,154 shares of the company's stock worth $570,000 after purchasing an additional 17,451 shares during the last quarter. Cetera Investment Advisers grew its holdings in shares of UiPath by 315.6% during the first quarter. Cetera Investment Advisers now owns 67,782 shares of the company's stock worth $1,537,000 after buying an additional 51,472 shares in the last quarter. Finally, Cetera Advisors LLC raised its position in shares of UiPath by 93.5% in the first quarter. Cetera Advisors LLC now owns 19,706 shares of the company's stock valued at $447,000 after buying an additional 9,522 shares during the last quarter. Hedge funds and other institutional investors own 62.50% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on PATH. Evercore ISI boosted their price target on shares of UiPath from $13.00 to $16.00 and gave the stock an "in-line" rating in a research report on Friday, September 6th. JPMorgan Chase & Co. lowered their target price on UiPath from $19.00 to $17.00 and set an "overweight" rating on the stock in a report on Wednesday, October 23rd. TD Cowen dropped their price target on UiPath from $17.00 to $16.00 and set a "hold" rating for the company in a research report on Friday, September 6th. Bank of America lifted their price objective on UiPath from $16.00 to $18.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Finally, Morgan Stanley restated an "equal weight" rating and issued a $15.00 target price on shares of UiPath in a report on Friday, September 6th. Sixteen investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $17.47.
View Our Latest Stock Report on PATH
Insider Buying and Selling
In other UiPath news, CFO Ashim Gupta sold 47,671 shares of the business's stock in a transaction on Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the transaction, the chief financial officer now owns 849,917 shares in the company, valued at $10,258,498.19. The trade was a 5.31 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 22.37% of the stock is owned by corporate insiders.
UiPath Stock Up 0.9 %
Shares of PATH traded up $0.12 during trading on Friday, reaching $14.21. 4,055,586 shares of the company traded hands, compared to its average volume of 9,469,106. The stock has a 50-day simple moving average of $12.90 and a 200-day simple moving average of $13.02. UiPath Inc. has a twelve month low of $10.37 and a twelve month high of $27.87. The stock has a market cap of $7.81 billion, a PE ratio of -71.05 and a beta of 0.87.
UiPath (NYSE:PATH - Get Free Report) last announced its earnings results on Thursday, September 5th. The company reported $0.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.01. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The company had revenue of $316.00 million for the quarter, compared to analyst estimates of $303.69 million. During the same quarter in the previous year, the company earned ($0.09) earnings per share. The firm's quarterly revenue was up 10.0% compared to the same quarter last year. On average, equities research analysts predict that UiPath Inc. will post -0.23 EPS for the current year.
UiPath Company Profile
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Read More
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.